The article examines aspects of the clinical course, diagnostics and treatment of various forms of cardiomyopathy (dilated, hypertrophic, restrictive) in children. Due to the relevance of the problem, the obtained data on the features of the clinical course, diagnostics and tactics of patient management are of interest to cardiologists, general practitioners and pediatricians of family clinics.

A total of 37 children aged 0-17 years were examined. Among those examined, the frequency of various forms of cardiomyopathy was: dilated - 62.1%, hypertrophic - 32.4%, restrictive - 5.4%. Anamnestic data, severity of the course, features of ECG, echocardiography, radiography for each form of cardiomyopathy were studied.

Latent, mild, but more often moderate and severe course of the disease was noted. Patients with DCM and HCM often have various rhythm and conduction disorders. Outpatient observation and timely (continuous) therapy of CHF are indicated for children with cardiomyopathies. In severe cases of HCM with obstructive forms of HCM, the issue of surgical treatment is considered.

Dilated, hypertrophic, restrictive cardiomyopathy

Strelyaeva A.V., Gasparyan E.R., Teres I.V., Zuev S.S., Sagieva A.T., Shadyeva Kh.N., Lazareva N.B., Sadykov V.M., Shcheglova T. A. Pecilomycotic atypical myocarditis in children and features of their treatment // RKZh. 2011. No. 5. URL: https://cyberleninka.ru/article/n/petsilomikoznye-atipichnye-miokardity-u-detey-i-osobennosti-ih-lecheniya:

Strelyaeva A.V., Shadyeva Kh.N., Lazareva N.B., Samylina I.A., Vakhrameeva I.V., Sadykov V.M., Mamatkulov Kh.M., Yakovlev A.O., Zuev S. . S. Toxic cardiopathy and myocarditis of pecilomycosis and other etiologies in children // RKZh. 2010. No. 3. URL: https://cyberleninka.ru/article/n/toksicheskaya-kardiopatiya-i-miokardity-petsilomikoznoy-i-inoy-etiologii-u-detey (date of access: 09/08/2024).

Shadieva H. N., Turdieva N.S., Kodirova M. M. Congenital complete atrioventricular blockade in children: clinical features and course, approaches to treatment // Journal of hepato-gastroenterological research. - 2022. - No. SI-3.

Shadieva H.N. Hypertrophic cardiomyopathies in children: a modern view of the problem // Problems of biology and medicine. - 2020. No. 3. Vol. 119. - P. 214-217. DOI: http://doi.org/10.38096/2181-5674.2020.3.00178

Qodirova MM, Shadiyeva XN Bolalarda norevmatik miokarditning EKGdagi asosiy simptomlari // Journal of gastroenterol. research, 2022; 3 (1): 33-365

Shadieva H.N., Khaidarova S.Kh., Mamutova E.S. Congenital heart disease: the scale of the problem, identification of risk factors for the development of congenital heart disease//J. Gastroenterological Research, 2021; 3.2(2):67-69 14.

Shadieva H.N., Khaidarova S.Kh., Mamutova E.S. Clinical case of dilated cardiomyopathy complicated by ventricular extrasystole and LV thrombus. // J. Gastroenterol. Research, 2021; 3.2(2):51-55 15

5.Kodirova M.M., Kholikova G.A.Main Clinical Signs Of Non-Rheumatic Myocarditis In Children Of Samarkand Region. //Journal of Medical and Natural Sciences. Vol 3.No. 2 (2023)

6.Kodirova M.M., Kholikova G.A..Samarqand xududida bolalarda miokarditning asosiy klinik simptomlarini uchrashi.Markhabo Miyasarovna Kodirova, Gulnoz Asatovna Kholikova.Journal of Hepato-Gastroenterology Research. Vol. 3 No. 2 (2022)

Clinical protocol for diagnosis and treatment of cardiomyopathy in children//Kazakhstan, 2015: 29 p.

Leontyeva I.V. Problems of modern diagnostics and treatment of dilated cardiomyopathy in children. Russian Bulletin of Perinatology and Pediatrics. 2018;63(2):7-15.

A.T. Shabanova, Haihai Liang, L.V. Yakovleva, T.A. Yagudin. A modern view of the intracellular mechanisms of the development of hypertrophic cardiomyopathy. Pediatrics named after G.N. Speransky. 2020; 99 (3): 207-211.

Sadykova D.I., Makarova T.P., Sabirova D.R., Firsova N.N., Kucheryavaya A.A., Shakurova N.V., Khasanova A.R. Familial form of dilated cardiomyopathy // Russian Bulletin of Perinatology. and ped., 2021, 66 (5):202-206

Bershova T.V., Basargina E.N., Bakanov M.I., Ivanov A.P. Dilated cardiomyopathy in children: molecular and cellular mechanisms of dysfunction.// Pediatrics named after G.N. Speransky. 2013; 92 (5).

Lipshultz SE, Cochran TR, Briston DA, Brown SR, Sambatakos PJ, Miller TL et al. Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies. Future Cardiol 2013; 9: 817-848.

Hong YM. Cardiomyopathies in children. Korean J Pediatr. 2013 Feb;56(2):52-9. doi: 10.3345/kjp.2013.56.2.52. Epub 2013 Feb 25. PMID: 23482511; PMCID: PMC3589591.

Alexander PM, Daubeney PE, Nugent AW, Lee KJ, Turner C, Colan SD et al. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation 2013; 128:2039-2046.

Latus H., Gummel K., Klinge K., Moysich A., Khalil M., Mazhari N. et al. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy. J Cardiovasc Magn Reson 2015; 17:34.

Halliday BP, Cleland JG, Goldberger JJ, Prasad SK Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation 2017; 136(2): 215-231.

Reddy S, Fung A, Manlhiot C, Tierney ES, Chung WK, Blume E, Kaufman BD et al. Adrenergic receptor geno-type influences heart failure severity and β-blocker response in children with dilated cardiomyopathy. Pediatr Res 2015; 77(2): 363-369.